10 of 11
GUBENDRAN ET AL.
[2] L. Li, K. D. Karlin, S. E. Rokita, J. Am. Chem. Soc. 2005, 127,
to cleave plasmid DNA even to very small extent. The
inability of the complex 2 to cleave plasmid pUC18 DNA
can be attributed to the ratio K+/K2+, obtained from CV
studies, which is less than unity. To have an observable
nuclease activity the ratio K+/K2+ should be >1.[46,47]
The cleavage mechanism may involve a hydroxyl radical
oxidative mechanism.
520.
[3] A. Silvestri, G. Barone, G. Ruisi, M. Giudice, S. Tumminello,
J. Inorg. Biochem. 2004, 98, 589.
[4] N. Nagesh, G. Raju, R. Srinivas, P. Ramesh, M. D. Reddy, C. R.
Reddy, Biochim. Biophys. Acta 2015, 1850, 129.
[5] G. Raju, R. Srinivas, M. D. Reddy, C. R. Reddy, N. Nagesh,
Nucleos. Nucleot. Nucl. Acids. 2014, 33, 489.
[6] J. D. Joshi, S. Sharma, G. Patel, J. J. Vora, Synth. React. Inorg.
Met‐Org.Chem. 2002, 31, 1729.
4 | CONCLUSION
[7] M. S. Surendra Babu, K. Hussain Reddy, P. G. Krishna, Polyhe-
dron 2007, 26, 572.
In summary, new anthracene based Schiff base ligands L1
and H(L2) and their derived Cu(II) complexes 1 and 2
have been synthesised and well characterized by using
various spectroscopic and analytical methods. The molec-
ular structures of the Cu(II) complexes 1 and 2 were
ascertained by a theoretical method (B3LYP/DFT analy-
sis). In vitro DNA binding studies have been performed
using various biophysical techniques viz., absorption,
cyclic voltammetry, and circular dichroism techniques,
to predict their binding mode as well as binding strength;
the results revealed higher binding affinity of complex 2
than complex 1, via groove mode of binding. For the rea-
son that, complex 1 has a bulkier in size than complex 2,
which make the barrier to bind with DNA via groove
mode of interaction. However, complex 1 showed signifi-
cant binding ability through electrostatic interaction with
DNA helix. We also analyzed the pUC18 DNA cleavage
capability of complex 2, which gives oxidative pathways
chase cleavage pattern. These results fortify our idea of
minor groove binding nature of complex 2 with DNA. In
conclusion, we believe that these Cu(II) complexes are
alternatives as better anticancer agents and additional
studies are needed on complex 2, to recommend as a
cancer drug in preclinical study.
[8] C. Tu, X. Wu, Q. Liu, X. Wang, Q. Xu, Z. Guo, Inorg. Chim. Acta
2004, 357, 95.
[9] A. Terenzi, R. Bonsignore, A. Spinello, C. Gentile, A.
Martorana, C. Ducani, B. Högberg, A. M. Almerico, A. Lauria,
G. Barone, RSC Adv. 2014, 4, 33245.
[10] A. Mederos, S. Dominguez, R. Hernandez‐Molina, J. Sanchiz, F.
Brito, Coord. Chem. Rev. 1999, 193, 857.
[11] D. M. Boghaei, S. Mohebi, Tetrahedron 2002, 58, 5357.
[12] M. S. Islam, M. A. Farooque, M. A. K. Bodruddoza, Synth.
React. Inorg. Met. Org. Chem. 2002, 32, 1811.
[13] R. C. Maurya, P. Patel, S. Rajput, Synth. React. Inorg. Met.‐Org.
Chem. 2003, 33, 817.
[14] N. Deligönül, M. Tümer, S. Serin, Transit. Metal. Chem. 2006,
31, 920.
[15] M. Tyagi, S. Chandra, J. Akhtar, D. Chand, Spectrochim. Acta A
Mol. Biomol. Spectrosc. 2014, 118, 1056.
[16] T. P. Ribeiro, C. Fernandes, K. V. Melo, S. S. Ferreira, J. A.
Lessa, R. W. A. Franco, G. Schenk, M. D. Pereira, A. Horn, Free
Radical Biol. Med. 2015, 80, 67.
[17] J. A. Prescher, C. R. Bertozzi, Nat. Chem. Biol. 2005, 1, 13.
[18] A. H. Osman, Trans. Met. Chem. 2006, 31, 35.
[19] S. M. Abdallah, M. A. Zayed, G. G. Mohamed, Arab. J. Chem.
2010, 3, 103.
[20] L. Chen, Y. Xiang, T. Feng, Appl. Organomet. Chem. 2012, 26,
ACKNOWLEDGEMENTS
108.
[21] P. Kavitha, M. Rama Chary, B. V. V. A. Singavarapu, K. Laxma
This work was supported by the DST‐SERB (Grant. No:
SB/FT/CS‐130/2012). We express our gratitude to
Madurai Kamaraj University and Mohamed Sathak
Engineering College, Kilakarai for their lab facilities and
their instrumentation facilities.
Reddy, J. Saudi, Chem. Soc. 2016, 20, 69.
[22] A. Gubendran, M. P. Kesavan, S. Ayyanaar, J. Dhaveethu Raja,
P. R. Athappan, J. Rajesh, Appl. Organomet. Chem. 2017, e3708.
[23] M. Damoder Reddy, E. Blake Watkins, J. Org. Chem. 2015, 80,
11447.
ORCID
[24] A. Golcu, M. Tumer, H. Demicell, R. C. Wheatley, Inorg. Chim.
Acta 2005, 358, 1785.
Jegathalaprathaban Rajesh
[25] P. G. Lacroix, F. Averseng, I. Malfant, K. Nakatani, Inorg. Chim.
Acta 2004, 357, 3825.
[26] S. Dhar, M. Nethaji, A. R. Chakravarty, Inorg. Chim. Acta 2005,
358, 2437.
REFERENCES
[1] R. Indumathy, S. Radhika, M. Kanthimathi, T. Weyhermuller,
[27] P. A. N. Reddy, B. K. Santra, M. Nethaji, A. R. Chakravarty,
B. Unni Nair, J. Inorg. Biochem. 2007, 101, 434.
J. Inorg. Biochem. 2004, 98, 377.